...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Events

 

foremm & Nbb - I too have been thinking that there is now a play for ZEN3694. I think they will have to tread a little carefully around the cross pollination as fouremm discibes. Not that it couldn't be done. It just increases the reporting that KD would have to do and if he is going to increase the reporting then why not just increase his position in RVX directly?

It would be nice to get some sort of update on Zenith and where they are at. Isn't it about time for a quarterly update?

tada 

Share
New Message
Please login to post a reply